GLUBIO THERAPEUTICS
GluBio Therapeutics focuses on molecular glue-targeted protein degradation and provides a multi-dimensional protein degradation screening platform, an innovative target validation platform, a molecular glue rational design platform, and a proprietary library of highly active molecules.
GLUBIO THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2021-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.glubiotx.com
Status:
Active
Total Funding:
72 M USD
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Series A - GluBio Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - GluBio Therapeutics
GL Ventures
GL Ventures investment in Series A - GluBio Therapeutics
E Fund Management Co.,LTD.
E Fund Management Co.,LTD. investment in Series A - GluBio Therapeutics
K2VC
K2VC investment in Series A - GluBio Therapeutics
Qiming Venture Partners
Qiming Venture Partners investment in Series A - GluBio Therapeutics
Kaitai Capital
Kaitai Capital investment in Series A - GluBio Therapeutics
Legend Capital
Legend Capital investment in Series A - GluBio Therapeutics
